Describe synthetic biology and engineered pathways

WHAT is Synthetic Biology?

Key vocabulary you must lock in:

Term	Meaning
Chassis	The host cell (e.g. E. coli, yeast) that carries the engineered parts
BioBrick	A standardized, reusable DNA part with defined connectors
Promoter	DNA sequence that controls when/how strongly a gene is switched on
Coding sequence (CDS)	The gene encoding the enzyme/protein
Terminator / poly(A) signal	Signal that stops transcription (bacteria: terminator; eukaryotes: polyadenylation signal)
Genetic circuit	Parts wired to sense inputs and produce logical outputs

WHY do it? (The 80/20 core)

The 20% that gives 80% of the marks:

Standardized parts (promoter + coding sequence + terminator/poly(A) = a "cassette").
Chassis hosts the parts.
Pathways redirect flux of a substrate toward a target product.
Real example: artemisinic acid in yeast; insulin in E. coli.

HOW is a pathway built? (Derivation from first principles)

Let's build the logic from scratch, not memorise it.

Step 1 — A gene must be expressed to make an enzyme. Why? Because only transcribed + translated DNA becomes a working enzyme. So the minimal unit — the expression cassette — is a set of parts that (a) start transcription, (b) let a ribosome start translation, (c) encode the protein, and (d) stop transcription. The exact parts depend on the chassis:

$\underbrace{\text{Promoter} \to \text{RBS} \to \text{CDS} \to \text{Terminator}}_{\textbf{Prokaryote (e.g. }E.\ coli\textbf{)}}$

$\underbrace{\text{Promoter} \to \text{5}'\text{-UTR/Kozak} \to \text{CDS} \to \text{poly(A) signal}}_{\textbf{Eukaryote (e.g. yeast)}}$

Why the difference? In bacteria a ribosome finds the mRNA via a Shine–Dalgarno / RBS sequence, and transcription ends at a simple terminator. In eukaryotes translation instead starts by scanning from the cap through a 5′-UTR / Kozak sequence, and the transcript must be polyadenylated (a poly(A) signal directs cleavage + tail addition) for stable, exportable mRNA — a bacterial RBS/terminator won't work there. Same logic (start–translate–stop), different molecular parts.

Step 2 — One enzyme makes one conversion. An enzyme $E_1$ converts substrate $S \rightarrow A$ . To reach a distant product we need a chain:

$S \xrightarrow{E_1} A \xrightarrow{E_2} B \xrightarrow{E_3} P$

Why chain them? Because no single enzyme jumps from $S$ to $P$ ; each step is a small chemical change catalysed by a specific enzyme. So we insert the cassettes for $E_1, E_2, E_3$ .

Step 3 — Balance the flux. If $E_2$ is slow, intermediate $A$ piles up (maybe toxic) and $P$ output falls. So we tune promoter strength to balance the "conveyor belt." This is the engineering insight nature never optimised for our product.

Figure — Describe synthetic biology and engineered pathways

Worked Examples

Worked example Example 2 — Insulin in

E. coli (recombinant single protein, but not "one simple polypeptide") Why chosen: Insulin is small and needs no long metabolic pathway — just heterologous expression. But it teaches that expression ≠ finished product. How (the honest version): Chemically synthesise DNA encoding proinsulin (or, in the original Genentech route, the A-chain and B-chain separately) → clone into a plasmid with a bacterial promoter (often fused to a carrier protein for stability) → transform into E. coli → bacteria transcribe & translate the precursor. Why it's NOT just "fold it": E. coli accumulates the precursor in inclusion bodies. It must be solubilised, refolded to form the correct disulfide bonds, and the connecting C-peptide proteolytically cleaved (proinsulin → mature insulin) before you get active human insulin. (Separate A/B chains are combined and oxidised to link the disulfides.) Why E. coli? It divides ~every 20 min, grows in cheap medium, and mass-culture is easy — 80/20 efficiency win.

Common Mistakes (Steel-manned)

Recall Feynman: Explain to a 12-year-old

Imagine your cell is a toy factory. Normal factories only build the toys they were born to build. Synthetic biology gives you a box of standard machine parts — an "on switch," a "start-reading tab," a "recipe card," and a "stop sign" — that you can snap into the factory to teach it to build a brand-new toy, like a medicine. But the tabs are different for different factories: a bacteria factory uses one kind of start-tab, a yeast factory uses another. And sometimes the toy comes out half-built (like insulin!) and needs an extra "trimming and stitching" station before it's ready. If the toy needs three machines in a row, you install all three, and you make sure none of them is too slow, or the whole line jams. That's an engineered pathway.

Flashcards

What is synthetic biology?

The design/construction of new biological parts, devices, and systems (or redesign of existing ones) using engineering principles like standardization and modularity.

What is a chassis in synthetic biology?

The host cell (e.g. E. coli or yeast) that carries and runs the engineered genetic parts.

Name the four functional parts of an expression cassette.

Promoter → translation-initiation element (RBS in bacteria / 5′-UTR-Kozak in eukaryotes) → coding sequence (CDS) → transcription stop (terminator in bacteria / poly(A) signal in eukaryotes).

How does a bacterial cassette differ from a eukaryotic (e.g. yeast) one?

Bacteria use a Shine–Dalgarno/RBS for ribosome binding and a simple terminator; eukaryotes use a 5′-UTR/Kozak sequence for translation initiation and a polyadenylation signal instead of a bacterial terminator/RBS.

What is a BioBrick?

A standardized, reusable DNA part with defined connectors so parts can be snapped together predictably.

Why do we multiply (not add) step efficiencies to get pathway yield?

Each step passes on only a fraction η_i of what it received; the surviving fractions compound, so total = [S]₀·∏η_i.

In a pathway with η₁=0.8 and η₂=0.5, what fraction of substrate reaches product?

0.8 × 0.5 = 0.40 (40%).

Why is E. coli a favoured chassis?

Fast division (~20 min), cheap growth medium, and easy scalable mass culture — ethical and economical.

Why is recombinant insulin production not simply "express and fold one polypeptide"?

E. coli expresses a precursor (proinsulin, or separate A- and B-chains); active insulin then requires correct disulfide-bond formation and proteolytic removal of the C-peptide.

Give a multi-step engineered pathway example.

Yeast engineered to make artemisinic acid by redirecting native FPP via amorphadiene synthase and cytochrome P450.

Why was insulin production moved into E. coli?

To avoid scarce/ethically problematic animal pancreas sources and get cheap, scalable, pure human insulin.

What does 'balancing flux' mean in an engineered pathway?

Tuning promoter strengths so no enzyme step is a bottleneck, preventing intermediate build-up and maximising product.

Difference between a promoter and a CDS?

Promoter = control switch deciding when/how strongly a gene is expressed; CDS = the recipe encoding the protein/enzyme.

Connections

Recombinant DNA Technology — the tools (restriction enzymes, plasmids) that make part-insertion possible
Gene Expression and Regulation — why promoters, RBS/Kozak and poly(A) signals control output
Metabolic Pathways — the natural enzyme chains we hijack or extend
Fermentation and Bioreactors — how engineered chassis are scaled up industrially
Insulin Production and Genetically Modified Organisms — flagship applications
Protein Folding and Post-translational Modification — why disulfide bonds and cleavage finish insulin
Enzymes and Catalysis — each pathway step is enzyme-catalysed

Concept Map

Hinglish (regional understanding)

Intuition Hinglish mein samjho

Dekho, synthetic biology ka simple matlab hai: cell ko ek programmable factory ki tarah treat karna. Jaise electronics mein hum standard parts (resistor, LED) ko breadboard pe jodte hain, waise hi hum DNA ke standard parts — promoter (switch), translation shuru karne wala element, CDS (enzyme ki recipe), aur ek stop signal — ko jodkar ek "cassette" banate hain. Yahan ek important baat: parts chassis pe depend karte hain. Bacteria (E. coli) mein ribosome ko RBS (Shine–Dalgarno) chahiye aur transcription ek simple terminator pe rukta hai. Lekin eukaryote jaise yeast mein translation 5′-UTR/Kozak sequence se start hoti hai aur transcript ko poly(A) signal se polyadenylate karna padta hai — bacterial RBS/terminator wahan kaam nahi karega. Logic same (start–translate–stop), parts alag.

Engineered pathway tab banta hai jab ek product tak pahunchne ke liye kai enzyme steps chahiye: $S \to A \to B \to P$ . Har enzyme sirf ek chhota chemical change karta hai, isliye poori chain install karni padti hai. Important — yield multiply hota hai, add nahi: $[P]=[S]_0 \times \eta_1\times\eta_2\times\dots$ . Agar koi ek step slow (leaky) hai, toh pura output gir jaata hai. Isliye asli engineering kaam hai flux balance karna — promoter strength tune karke bottleneck step theek karna.

Ek dhyaan dene wali baat: insulin ka case. Log sochte hain bas gene express karo aur insulin ban gaya. Galat! E. coli asal mein ek precursor banata hai — proinsulin, ya original method mein alag-alag A-chain aur B-chain. Uske baad disulfide bonds sahi se banane padte hain aur C-peptide ko proteolytic cleavage se hatana padta hai, tab jaake active human insulin milta hai. Matlab expression zaroori hai lekin kaafi nahi — thoda "trimming aur stitching" bhi chahiye.

Ye sab matter kyun karta hai? Kyunki artemisinin jaisi malaria dawa plant se banane mein mahine lagte hain, aur insulin pehle suar ke pancreas se aata tha. In pathways ko fast-growing microbe mein daal do, toh fermentation tank mein sasta, scalable aur ethical production ho jaata hai. Yaad rakho F.C.E. — Fast growth, Cheap medium, Ethical/scalable — aur cassette order: Please Read Carefully, Then stop = Promoter, RBS/Kozak, CDS, Terminator/poly(A).

Test yourself — Biotechnology Applications

Connections